Company

SignalPath, LLC

SignalPath, LLC provides the Viewpoint Site CTMS clinical trial management platform for research sites and healthcare organizations.

About

Founded in 2014 and based in Raleigh, US, SignalPath, LLC makes clinical trial management software. It was co-founded by Bradly Nicholls and Kevin Monroe, with Bradly Nicholls serving as CEO. Its Viewpoint Site CTMS platform digitizes study protocols and is sold on a subscription basis with bundled analytics and integration services. The company raised USD 18.18 mn in Series B funding and was acquired by Verily Life Sciences LLC in August 2021.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in